We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.37%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
201
Huber Capital Management
California
$17.6M +$228K +1,100 +1%
AAM
202
Aberdeen Asset Management
United Kingdom
$17.4M +$12.4M +59,779 +327%
PSUF
203
People's United Financial
Connecticut
$17.4M -$1.66M -8,020 -9%
BCM
204
Brigade Capital Management
New York
$16.8M +$15.6M +75,500 New
PAAMCP
205
Pacific Alternative Asset Management Company (PAAMCO)
California
$16.8M +$11.2M +53,980 +252%
PIM
206
Partner Investment Management
California
$16.7M -$5.14M -24,804 -25%
TPSF
207
Texas Permanent School Fund
Texas
$16.6M -$388K -1,874 -2%
ARC
208
Absolute Return Capital
Massachusetts
$16.6M +$5.28M +25,494 +51%
AIA
209
Affinity Investment Advisors
California
$16.4M -$2.6M -12,564 -15%
BTS
210
BB&T Securities
Virginia
$16.3M +$388K +1,872 +34%
CB
211
Commerce Bank
Missouri
$16M +$4.67M +22,560 +46%
SOMRS
212
State of Michigan Retirement System
Michigan
$15.9M +$82.8K +400 +0.6%
Aviva
213
Aviva
United Kingdom
$15.9M -$114K -550 -0.8%
Public Sector Pension Investment Board (PSP Investments)
214
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$15.5M +$1.19M +5,762 +9%
MTIP
215
Magee Thomson Investment Partners
California
$15.5M -$12.4M -59,800 -46%
NFA
216
Nationwide Fund Advisors
Ohio
$15.3M +$2.03M +9,793 +17%
AIG
217
American International Group
New York
$15.1M -$1.05M -5,061 -7%
FMI
218
Factory Mutual Insurance
Massachusetts
$14.9M +$13.9M +67,000 New
JMH
219
J.M. Hartwell
New York
$14.9M +$569K +2,750 +4%
Comerica Bank
220
Comerica Bank
Texas
$14.9M -$1.9M -9,189 -12%
RSCM
221
Rock Springs Capital Management
Maryland
$14.7M +$1.97M +9,500 +17%
ZIM
222
Zacks Investment Management
Illinois
$14.4M -$1.34M -6,488 -9%
ARTA
223
A.R.T. Advisors
New York
$14.3M +$13.2M +63,923 New
SFM
224
Soros Fund Management
New York
$14.2M +$5.97M +28,831 +82%
GH
225
GAM Holding
Switzerland
$13.9M +$4.7M +22,709 +57%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.